Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EPS (Weighted Average and Diluted): 2015-2023

Historic EPS (Weighted Average and Diluted) for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$0.31.

  • Cellectis' EPS (Weighted Average and Diluted) rose 50.79% to -$0.31 in Q3 2023 from the same period last year, while for Sep 2023 it was -$1.68, marking a year-over-year increase of 26.96%. This contributed to the annual value of -$2.33 for FY2022, which is 8.63% up from last year.
  • According to the latest figures from Q3 2023, Cellectis' EPS (Weighted Average and Diluted) is -$0.31, which was down 55.00% from -$0.20 recorded in Q2 2023.
  • Cellectis' 5-year EPS (Weighted Average and Diluted) high stood at $0.47 for Q1 2020, and its period low was -$0.95 during Q4 2020.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.54, with a median of -$0.58 in 2023.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first slumped by 364.71% in 2019, then surged by 230.56% in 2020.
  • Over the past 5 years, Cellectis' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.88 in 2019, then decreased by 7.95% to -$0.95 in 2020, then skyrocketed by 42.11% to -$0.55 in 2021, then fell by 7.27% to -$0.59 in 2022, then skyrocketed by 50.79% to -$0.31 in 2023.
  • Its last three reported values are -$0.31 in Q3 2023, -$0.20 for Q2 2023, and -$0.58 during Q1 2023.